Seeger Weiss Expands Presence in Philadelphia with New Office in Historic Old City

PHILADELPHIA, PA – Nationally recognized mass tort and class action law firm Seeger Weiss today announced the grand opening of its expanded Philadelphia presence in the historic Old City. The new 5,000-square-foot office near Independence Hall (325 Chestnut Street, Suite #917) positions the firm’s deep trial expertise steps from the federal courthouse and signals its […]

October 24, 2024

PHILADELPHIA, PA – Nationally recognized mass tort and class action law firm Seeger Weiss today announced the grand opening of its expanded Philadelphia presence in the historic Old City. The new 5,000-square-foot office near Independence Hall (325 Chestnut Street, Suite #917) positions the firm’s deep trial expertise steps from the federal courthouse and signals its growing commitment to serving clients in the region and across the country in high-stakes cases. Seeger Weiss selected partner Shauna Itri, a longtime pillar of the local legal community, to lead the firm’s Philadelphia office.

“We are thrilled to grow our firm’s presence in Philadelphia, a city that has long been a crucial venue for complex litigation,” said Itri. “This expansion reflects our dedication to providing exceptional representation to clients while deepening our roots in this vibrant legal community.”

Seeger Weiss has played a leading role in landmark mass tort and multidistrict litigation cases, including the NFL Concussion Litigation, the National Prescription Opioid Litigation, the Volkswagen “Clean Diesel” Litigation, and the 3M Combat Arms Earplug Litigation. The firm is doubling its Philadelphia footprint with plans to expand local staff by leveraging the city’s robust talent pipeline.

“Our firm has long led major cases in the Eastern District of Pennsylvania – from the NFL Concussion Litigation to our current leadership role in the GLP-1 Litigation. Strengthening our presence in Philadelphia was a natural next step,” said Seeger Weiss co-founder Chris Seeger. “Our new office represents more than just additional square footage—it’s a strategic investment in our firm’s future and our commitment to serving clients throughout Pennsylvania and beyond.”

The new office is situated close to the Eastern District of Pennsylvania courthouse, a pivotal venue for many of Seeger Weiss’s clients. The office opening follows the hiring earlier this year of partner Benjamin R. Barnett, who joined the firm’s Philadelphia team from Dechert where he chaired the Product Liability and Mass Tort Practice Group.

One of the nation’s preeminent plaintiffs’ law firms, Seeger Weiss is best known for multidistrict mass torts and class actions in both state and federal court—and especially for taking those cases to trial. With the resources and dedication to take on the world’s largest corporations, the firm has an impressive track record of victories against companies like Merck, Monsanto, and 3M—and a reputation for sticking with a case from beginning to end. From offices in New York, New Jersey, and Pennsylvania, the firm has represented over 10,000 individuals, companies, and governments across the United States who have been injured or defrauded on a massive scale. Since its founding in 1999, it has led many of the most complex and high-profile cases in the country: the National Prescription Opiate Litigation, which the Washington Post called “the largest federal court case in U.S. history”; the ongoing “Dieselgate” scandal; the sprawling multistate litigation on behalf of survivors of child sexual abuse; and the history-making National Football League Players’ Concussion Injury Litigation.

Prior results do not guarantee or predict a similar outcome in any future matter.

Related News

July 28, 2026
Seeger Weiss Named Pharmaceutical Litigation Practice Group of the Year at the National Law Journal’s 2026 Elite Trial Lawyers Awards

Seeger Weiss has been named as Pharmaceutical Litigation Practice Group of the Year at the National Law Journal’s 2026 Elite Trial Lawyers Awards. This honor is reflects to the Seeger Weiss team’s efforts throughout the entire Pharmaceutical Litigation practice area, but specifically the firm’s work on the GLP-1 RA and Depo-Provera litigations. Partner Parvin Aminolroaya […]

Read More
July 28, 2026
Plaintiffs Reach Uncapped Global Settlement With J&J, Company to Pay Minimum of $5.8 Billion to Resolve Talc Litigation After More Than a Decade

The Plaintiffs’ Negotiation Committee in multi-district litigation 2738 (District of New Jersey), with the support and endorsement of the Plaintiffs’ Executive Committee and the Plaintiffs’ Steering Committee, announces today that it has reached a historic $5.8 billion settlement with Johnson & Johnson to resolve all current and pending talcum powder claims in MDL No. 2738 […]

Read More
June 29, 2026
Seeger Weiss Earns Tier 1 Ranking in the 2026 Legal 500 USA Guide

Seeger Weiss is proud to announce that the firm has been selected for a Tier 1 ranking in the 2026 Legal 500 USA Guide in the Product Liability, Mass Tort and Class Action: Plaintiff category. Founding Partner Christopher Seeger was selected for inclusion in the category’s Hall of Fame in recognition of his continued leadership […]

Read More